Topics
March 2012 | Perspectives: from The Editors Of New Retina Md
The Sunshine Act's Intimidation Factor
Will the noble objectives of this law set up a roadblock to innovation?
Richard S. Kaiser, MD, and Jonathan L. Prenner, MD
July 8, 2026
Cascade Prodrug Expands Collaboration with Netherlands-Based Uneedle to Advance Hypoxia-Targeted Wet AMD Therapy
MeiraGTx Secures Financing Package of Up to $400 Million to Advance Gene Therapies
July 7, 2026
France-based AcuSurgical Appoints Pierre Billardon as Board Chairman
July 2, 2026
Study Links Sleep Disorders With Increased Odds of Developing AMD
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Supported by Zeiss
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Editorially independent content supported by advertising from Genentech
Free Print Subscription
Email Newsletter
Conference Calendar
